CYNTHIA DAY: Open Payments
NPI 1336424522 · LAFAYETTE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,464 in 80 payments from 19 companies in 2025. Trend: 2023 $1,348 · 2024 $978 · 2025 $1,464
Food & beverage: $1,464
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $292 |
| Novo Nordisk Inc | 14 | $224 |
| PFIZER INC. | 9 | $156 |
| Otsuka America Pharmaceutical, Inc. | 5 | $88 |
| Lilly USA, LLC | 5 | $86 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $84 |
| AstraZeneca Pharmaceuticals LP | 5 | $83 |
| Axsome Therapeutics, Inc. | 3 | $78 |
| Lundbeck LLC | 3 | $63 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $57 |
Products named: Ozempic, VRAYLAR, REXULTI, XIFAXAN, NURTEC ODT, AIRSUPRA, CAPLYTA, QULIPTA.
Industry payments across GA — which companies pay providers there.
